Continued funding for cancer research is essential to the development of molecular oncology and is a primary driver of market ...

NANTES, France, October 17, 6:00pm CET - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), today announced it will be presenting its ...

Malcolm Ethridge, Capital Area Planning Group managing partner, joined CNBC to talk about where the market could go and his ...

The global high potency API (HPAPI) contract manufacturing market achieved a market value of USD 8 billion in 2022 and is ...

Diakonos’ dendritic cell vaccine represents a unique approach for engaging an immune response against a patient’s cancer.

October 7, 2024 (Investorideas.com Newswire) Investorideas.com (www.investorideas.com), a go-to platform for big investing ideas for stock traders, including biotech stocks reports on trading and news ...

As global markets experience shifts with interest rate adjustments and economic indicators showing mixed signals, the Hong Kong market remains a focal point for investors seeking opportunities in high ...

On September 30, 2024, Empery Asset Management, LP (Trades, Portfolio) made a significant addition to its investment ...

The Swiss market recently demonstrated resilience by rebounding from a weak start, buoyed by the European Central Bank's interest rate cut to 3.25%, which helped lift the SMI index by 0.91% to close ...

AKT1 E17K mutation is a clinically validated oncogene that impacts greater than 40,000 cancer patients per year in the United States, with the highest prevalence in breast, endometrial, and prostate ...